Respondek et al. [7] have shown that temozolomide demonstrates a significantly lower cytotoxic effect, even in the highest drug concentration (100 μM) and 72 h of incubation time on U87MG glioblastoma cells when compared with MIM1 and MIM1/temozolomide mixture. This evidence concerns the gene MIMT1 and glioblastoma.